| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/28/2010 | WO2010009987A2 Diagnostic antibody assay |
| 01/28/2010 | WO2010009985A2 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 01/28/2010 | WO2010009856A2 Goodpasture antigen binding protein and its detection |
| 01/28/2010 | WO2009148915A3 Methods for predicting patient response to modulation of the co-stimulatory pathway |
| 01/28/2010 | WO2009147530A3 Conformation specific antibodies that bind trefoil factors |
| 01/28/2010 | WO2009147201A3 Anti-inflammatory agents |
| 01/28/2010 | WO2009137113A3 Peptides, antibodies, and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 01/28/2010 | WO2009090656A3 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 01/28/2010 | WO2007024941A3 Polyvalent vaccine |
| 01/28/2010 | WO2004005463A9 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/28/2010 | US20100021995 Biological products |
| 01/28/2010 | US20100021976 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/28/2010 | US20100021548 Use of microparticles with adsorbed antigen to stimulate immune responses |
| 01/28/2010 | US20100021546 Controlled-release immunogenic formulations to modulate immune response |
| 01/28/2010 | US20100021504 Treatment and prevention of allergic airways diseases |
| 01/28/2010 | US20100021503 Immunogenic composition |
| 01/28/2010 | US20100021502 Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT |
| 01/28/2010 | US20100021501 Live vaccine strains of francisella |
| 01/28/2010 | US20100021500 Processes for treating subjects carrying viral infectious agent |
| 01/28/2010 | US20100021499 Cell-based systems for producing influenza vaccines |
| 01/28/2010 | US20100021498 Live, attenuated pneumococcal vaccine |
| 01/28/2010 | US20100021497 Ipv-dpt vaccine |
| 01/28/2010 | US20100021496 Methods, kits, and antibodies for quantitative determination of parathyroid hormone molecules with intact c-terminus |
| 01/28/2010 | US20100021492 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 01/28/2010 | US20100021491 PROTEIN KINASE DEFICIENT, IMMUNOLOGICALLY ACTIVE CMVpp65 MUTANT CELLULAR VACCINES |
| 01/28/2010 | US20100021490 Preparation of soluble N-protein/truncated P-protein complexes or N-proteinssoluble in a virus of the paramyxoviridae family and use thereof in vaccines |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/28/2010 | US20100021488 Hmgn polypeptides as immune enhancers and hmgn antagonists as immune suppressants |
| 01/28/2010 | US20100021487 Vaccines and methods for controlling adiposity |
| 01/28/2010 | US20100021486 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 01/28/2010 | US20100021485 Combination therapy method and formulation |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021483 Humanized anti-5t4 antibodies and anti-5t4/calicheamicin conjugates |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021481 Conjugates of an anti-tnf-alpha antibody |
| 01/28/2010 | US20100021480 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 01/28/2010 | US20100021479 Monoclonal Antibodies Against CD30 Lacking in Fucosyl Residues |
| 01/28/2010 | US20100021478 Diagnostic antibody assay |
| 01/28/2010 | US20100021477 DESIGN AND GENERATION OF HUMAN DE NOVO pIX PHAGE DISPLAY LIBRARIES |
| 01/28/2010 | US20100021476 High Affinity Human Antibodies to Human IL-4 Receptor |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021474 Methods and compositions for targeting hepsin |
| 01/28/2010 | US20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor |
| 01/28/2010 | US20100021472 Methods for diagnosing and treating cancer |
| 01/28/2010 | US20100021471 Carbon nanotube-based drug delivery systems and methods of making same |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021464 Methods of wound care and treatment |
| 01/28/2010 | US20100021463 Antibodies to ip-10 for treating bone diseases with bone destruction |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021461 Immunoglobulin formulation and method of preparation thereof |
| 01/28/2010 | US20100021460 Methods of Treating Autoimmune Diseases Using CD4 Antibodies |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021458 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/28/2010 | US20100021457 Detection system and uses therefor |
| 01/28/2010 | US20100021456 Drug for inhibiting,preventing or treatment of rheumatoid arthritis |
| 01/28/2010 | US20100021455 Methods for diagnosis and treatment of crohn's disease |
| 01/28/2010 | US20100021454 Antibodies With Immune Effector Activity And That Internalize In Endosialin-Positive Cells |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021452 Compositions and methods of use for therapeutic antibodies |
| 01/28/2010 | US20100021451 Uses and compositions for treatment of ankylosing spondylitis |
| 01/28/2010 | US20100021428 Use Of Gelsolin To Treat Multiple Sclerosis And To Diagnose Neurologic Disease (Stossel) |
| 01/28/2010 | US20100021420 Combinations of pyrazole derivatives for the inhibition of cdks and gsk's |
| 01/28/2010 | US20100021384 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 01/28/2010 | US20100021379 Chemical Antibodies for Immunotherapy and Imaging |
| 01/28/2010 | CA2736842A1 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | CA2733218A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2732228A1 Methods and compositions for treating and preventing autoimmune diseases |
| 01/28/2010 | CA2731842A1 Compositions and methods for the treatment of hepatitis c |
| 01/28/2010 | CA2731549A1 Novel compositions and methods |
| 01/28/2010 | CA2731547A1 The tuberculosis rv2386c protein, compositions and uses thereof |
| 01/28/2010 | CA2731499A1 Novel compositions and methods |
| 01/28/2010 | CA2731255A1 Structural variants of antibodies for improved therapeutic characteristics |
| 01/28/2010 | CA2731242A1 Compositions and methods related to sirt1 function |
| 01/28/2010 | CA2731091A1 Therapy targeting cancer stem cells |
| 01/28/2010 | CA2731044A1 Diagnostic antibody assay |
| 01/28/2010 | CA2730132A1 Novel angiopoietin derived peptides |
| 01/27/2010 | EP2147978A2 N-Terminally truncated HER-2/NEU protein as a cancer prognostic indicator |
| 01/27/2010 | EP2147930A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147929A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147928A2 Peptide-based immunization therapy for treatment of atherosclerososis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147926A1 Truncated human papillomavirus type 18 l1 proteins |
| 01/27/2010 | EP2147682A2 Vaccination with immuno-isolated cells producing an immunomodulator |
| 01/27/2010 | EP2147680A2 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 01/27/2010 | EP2147672A1 Cytotoxic t cell activator comprising ep4 agonist |
| 01/27/2010 | EP2146748A1 Macrophage transfection method |
| 01/27/2010 | EP2146746A2 Prevention and treatment of cerebral amyloid angiopathy |
| 01/27/2010 | EP2146745A2 Novel compounds |
| 01/27/2010 | EP2146743A2 New virulence factors of streptococcus pneumoniae |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP2146694A1 Formulation of active agent loaded activated plga nanoparticles for targeted cancer nano-therapeutics |
| 01/27/2010 | EP1924605B1 Compositions and methods for diagnosing and treating an inflammation |
| 01/27/2010 | EP1786931B1 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 01/27/2010 | EP1732949B1 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 01/27/2010 | EP1594466B1 Virosome-like-particles |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |